NR1H4 and obesity due to melanocortin 4 receptor deficiency: Moreover, FXR also showed effective therapeutic effect on nonalcoholic fatty liver disease (NAFLD) and metabolic diseases including obesity, diabetes, and hypercholesterolemia (Wang et al., 2018).